Navigation Links
The remarkable history of medicine's battle with infectious diseases
Date:9/14/2011

For those fascinated by microbes, infection, or how medical discoveries shape our modern understanding, Germ Theory: Medical Pioneers in Infectious Diseases, a new book just published by ASM Press, brings to life the stories of a dozen medical pioneers whose work changed the way we think about and treat infection.

Through a series of biographies, Dr. Robert Gaynes describes the genesis of the germ theory of disease and presents the inside stories of medical pioneers, from Hippocrates and Avicenna to Paul Ehrlich and Lillian Wald and the struggles they overcame to have their work accepted.

For example, readers will learn how Robert Koch discovered the bacterium that causes tuberculosis; how Edward Jenner, the pioneer of vaccination, faced down scores of naysayers; and, how a chance discovery led Louis Pasteur to the idea that virulence of microbes can be altered.

"My intent in writing this book was to offer a series of lessons that can inform strategies for tackling current crises in infectious diseases and can motivate and support today's scientists," says Dr. Gaynes.

"Germ Theory is a delightful and fascinating read for everyone interested in the remarkable history of medicine's battle against communicable disease. I thoroughly enjoyed it and highly recommend it," says Robert C. Moellering, Jr., MD, Shields Warren-Mallinckrodt Professor of Medical Research, Harvard Medical School.

Robert P. Gaynes, MD, is a Professor of Medicine (Infectious Diseases) at Emory University School of Medicine, where he teaches a course on the history of medicine. He also serves as an Attending Physician and the Chair of the Infection Control Committee at the Atlanta VA Hospital. Dr. Gaynes has authored or coauthored over 135 papers and book chapters on infectious disease topics. He is currently the host for the Centers for Disease Control and Prevention (CDC) weekly MMWR podcast.

Germ Theory: Medical Pioneers in Infectious Diseases has a list price of $29.95 and can be purchased through ASM Press online at http://estore.asm.org/press or through other online retailers.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. National new biology initiative offers potential for remarkable and far-reaching benefits
2. Remarkable biological complexity of bacterial cells is focus of newly released book
3. Study finds remarkable diversity of lichen species in Florida state park
4. New study indicates link between weight gains during pregnancy and dieting history
5. Revealing the evolutionary history of threatened sea turtles
6. Human connection to our nations fisheries comes alive through oral history project
7. Italys geologic history becomes a personal tale in Walter Alvarezs new book
8. NJIT history professor receives national endowment for humanities
9. Chantix side effects no worse with depression history
10. Study of protein structures reveals key events in evolutionary history
11. DOE makes largest Danforth Campus research award in history
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
(Date:6/23/2016)... ... 2016 , ... Velocity Products, a division of Morris Group, ... exclusively for Okuma CNC machining centers at The International Manufacturing Technology Show, IMTS, ... companies with expertise in toolholding, cutting tools, machining dynamics and distribution, Velocity SMART ...
Breaking Biology Technology: